Article citationsMore>>

Grey, A., Bolland, M., Gamble, G., Wattie, D., Horne, A., Davidson, J. and Reid, I.R. (2007) The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: A randomized, controlled trial. Journal of Clinical Endocrinology & Metabolism, 92, 1305-1310. doi:10.1210/jc.2006-2646

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
+1 323-425-8868
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top